Luxembourg - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)

Since 2014, Luxembourg Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) rose 1.2% year on year. In 2019, the country was ranked number 6 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) at €398.82 Per Capita. Luxembourg is overtaken by France, which was number 5 at €412.39 Per Capita and is followed by Austria with €372.81 Per Capita. Switzerland topped the ranking with €665.57 Per Capita in 2019, an increase of 3.2% compared to 2018. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland recorded the best 5 years average growth at +5.4% per year, while Portugal witnessed the worst performance at -12.9% per year.

Loading...

Date Euros Per Capita
2019 398.82
2018 399.66
2017 389.05
2016 385.78
2015 384.59
Download all data from 2011 to 2019

How does Luxembourg rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?

# 23 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
665.57 2019 +3.1 % +5.3 % View data
2 #2
Germany
524.79 2019 +2.3 % +3.0 % View data
5 #5
France
412.39 2019 +0.6 % +1.9 % View data
6 #6
Luxembourg
398.82 2019 -0.2 % +1.2 % View data
7 #7
Austria
372.81 2019 +0.8 % +2.2 % View data
Compare all 23 countries

Go Top